Franklin M Berger is Director of FIVE PRIME THERAPEUTICS, INC.. Currently has a direct ownership of 0 shares of FPRX, which is worth approximately $0. The most recent transaction as insider was on Apr 16, 2021, when has been sold 5,000 shares (Common Stock) at a price of $38.0 per share, resulting in proceeds of $190,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

FRANKLIN M BERGER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 16 2021
SELL
Sale (or disposition) back to the issuer
$190,000 $38.0 p/Share
5,000 Reduced 100.0%
0 Common Stock

Also insider at

AVIR
Atea Pharmaceuticals, Inc. Healthcare
EPIX
ESSA Pharma Inc. Healthcare
RAIN
Rain Therapeutics Inc. Healthcare
BCEL
Atreca, Inc. Healthcare
KZR
Kezar Life Sciences, Inc. Healthcare
FMB

Franklin M Berger

Director
Newark, CA

Track Institutional and Insider Activities on FPRX

Follow FIVE PRIME THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FPRX shares.

Notify only if

Insider Trading

Get notified when an Five Prime Therapeutics, Inc. insider buys or sells FPRX shares.

Notify only if

News

Receive news related to FIVE PRIME THERAPEUTICS, INC.

Track Activities on FPRX